Importo totale (1 articolo articoli):
Destinazione ordine:
kinney jefferson (24 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (24)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (Nessun altro risultato corrispondente a questo perfezionamento)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
- Nuovo (16)
- Come nuovo, Ottimo o Quasi ottimo (4)
- Molto buono o Buono (4)
- Discreto o Mediocre (Nessun altro risultato corrispondente a questo perfezionamento)
- Come descritto (Nessun altro risultato corrispondente a questo perfezionamento)
Legatura
Ulteriori caratteristiche
- Prima ed. (Nessun altro risultato corrispondente a questo perfezionamento)
- Copia autograf. (Nessun altro risultato corrispondente a questo perfezionamento)
- Sovracoperta (Nessun altro risultato corrispondente a questo perfezionamento)
- Con foto (2)
- Non Print on Demand (17)
Lingua (1)
Spedizione gratuita
Paese del venditore
Valutazione venditore
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 3,34
Spedizione EUR 6,49
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Fine.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
hardcover. Condizione: Very Good. Open Books is a nonprofit social venture that provides literacy experiences for thousands of readers each year through inspiring programs and creative capitalization of books.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Books From California, Simi Valley, CA, U.S.A.
Valutazione del venditore 4 su 5 stelle
hardcover. Condizione: Good. Cover and edges may have some wear.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Books From California, Simi Valley, CA, U.S.A.
Valutazione del venditore 4 su 5 stelle
hardcover. Condizione: Very Good. Cover and edges may have some wear. Mild to Moderate creasing / bending to covers and pages.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem [Hardcover] [Mar 31, 2022] Cummings, Jeffrey; Kinney, Jefferson and Fillit, Howard
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Zebra Books, Cambridge, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 23,86
Spedizione EUR 23,17
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Very Good. Remainder with a "damaged" stamp to copyright page - upper board corners slightly bumped - minimal surface wear - very good condition.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Prior Books Ltd, Cheltenham, Regno Unito
Membro dell'associazione: ABA ILAB PBFA
Valutazione del venditore 5 su 5 stelle
EUR 29,83
Spedizione EUR 25,49
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Like New. A firm and square hardback with sharp corners and strong joints just showing a few very minor rubs. Hence a non-text page has a small 'damaged' stamp. Despite such this book is actually in nearly new condition and appears unread. Thus the contents are crisp, fresh and tight. Also, no pen-marks and not from a library so no such stamps or labels. Now offered for sale at a very sensible price.
-
Alzheimer's Disease Drug Development : Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: California Books, Miami, FL, U.S.A.
Valutazione del venditore 4 su 5 stelle
EUR 145,96
Spedizione gratuita
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 132,72
Spedizione EUR 13,88
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Alzheimer's Disease Drug Development : Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 132,71
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Alzheimer's Disease Drug Development : Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Valutazione del venditore 5 su 5 stelle
EUR 153,96
Spedizione EUR 10,50
Spedito da Irlanda a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Alzheimer's Disease Drug Development : Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 153,93
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. New edition NO-PA16APR2015-KAP.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Kennys Bookstore, Olney, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 193,83
Spedizione EUR 9,07
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 200,74
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock.
-
Alzheimer's Disease Drug Development
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
EUR 236,63
Spedizione EUR 66,32
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing.
-
Alzheimer's Disease Drug Development (Hardcover)
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 136,14
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock. This item is printed on demand.
-
Alzheimer's Disease Drug Development (Hardcover)
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: CitiRetail, Stevenage, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 149,13
Spedizione EUR 42,86
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
-
Alzheimer\ s Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
EUR 144,48
Spedizione EUR 48,99
Spedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a definitive overview of the complex ecosystem facilitating Alzheimer s Disease drug research and development. Demonstrates a drug s journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Deta.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 198,21
Spedizione EUR 7,53
Spedito da Regno Unito a U.S.A.Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
-
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: Biblios, Frankfurt am main, HESSE, Germania
Valutazione del venditore 4 su 5 stelle
EUR 201,79
Spedizione EUR 9,95
Spedito da Germania a U.S.A.Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
-
Alzheimer's Disease Drug Development (Hardcover)
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Da: AussieBookSeller, Truganina, VIC, Australia
Valutazione del venditore 5 su 5 stelle
EUR 200,33
Spedizione EUR 31,97
Spedito da Australia a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
